We have constructed two fusion proteins T-hIL-2 and T-mIL-3 in which human interleukin-2 (hIL-2) or murine interleukin-3 (mIL-3) are fused to the C-terminus of the diphtheria toxin transmembrane domain (T domain). Two additional fusion proteins, T-(Gly 4 -Ser) 2 -hIL-2 and T-(Gly 4 -Ser) 2 -mIL-3, were derived by introduction of the (Gly 4 -Ser) 2 spacer between the T domain and cytokine components. Recognition of the hIL-2 receptor or the mIL-3 receptor by the corresponding recombinant proteins was demonstrated by their capacity to stimulate cytokine-dependent cell lines. All proteins retained the capacity of the T domain to insert into phospholipid membranes at acidic pH. Finally, anchoring of both cytokines to the membrane of lipid vesicles or living cells was assessed by specific antibody recognition. Our results show that the T domain fused to the N-terminus of a given protein can function as a pH sensitive membrane anchor for that protein.
Introduction
Attachment of proteins to membranes has met with growing interest in the past 15 years, for studies ranging from ligandreceptor interactions to the design of cell-targeted immunoliposomes. The expression of a soluble protein on the surface of cells is usually achieved by recombinant gene transfection after the fusion of a transmembrane sequence to that protein.
For synthetic membranes, anchoring of proteins such as antibodies is performed by chemical coupling either to a derivatized phospholipid initially incorporated into the membrane or to an acylated chain which will further be incorporated into the lipid bilayer, often with the help of detergents. Unconjugated molecules must be eliminated by purification. Recently, it was shown that acylation of a recombinant scFv could also be performed biosynthetically, but membrane insertion still requires the use of detergents (de Kruif et al., 1996) . The drawback is that detergents must be removed through time consuming steps, and small amounts may remain trapped in the membranes.
Our objective was to design a membrane anchor which would allow for the attachment of soluble proteins to synthetic or natural phospholipid bilayers as well, in a simple manner.
Anchoring should be fast, and easily triggered when desired, without the need for detergents or chemical cross-linking reagents which interfere with membranes or cell surface proteins.
Most bacterial toxins interact with cell membranes. Many of them share the remarkable property of being water-soluble proteins which are capable of self insertion into biological membranes (reviewed in Menestria et al., 1994) . A large group of bacterial toxins have an intracellular target and must translocate a catalytic domain through the cell membrane into the cytoplasm to exert their toxic activity. This translocation process involves a transmembrane domain, devoid of toxicity by itself, which facilitates the delivery of a toxic catalytic domain into the cytosol. Diphtheria toxin is the one for which this process is the most understood (Choe et al., 1992; Bennett et al., 1994; Lemichez et al., 1997) . Briefly, after binding by its receptor binding domain to its cell surface receptor, a heparin-binding EGF-like membrane precursor (Naglich et al., 1992; Iwamoto et al., 1994) , diphtheria toxin is internalized through the clathrin-coated endocytic pathway. Acidification of the endocytic compartment causes insertion of the transmembrane (T) domain of the toxin into the membrane of the endosome (Sandvig and Olsnes, 1981; Choe et al., 1992; Bennett et al., 1994; Lemichez et al., 1997) . This event plays a key role in translocation of the catalytic domain to the cytoplasm (vanderSpek et al., 1994a,b) . Acidic pH membrane insertion of diphtheria toxin (London, 1992; Cabiaux et al., 1994; Quertenmont et al., 1996; Wang et al., 1997a) or the isolated T domain (Zhan et al., , 1995 Wang et al., 1997b) or T domain fragments (Silverman et al., 1994; Oh et al., 1996) have been extensively studied on synthetic lipid bilayers and is well documented. These studies have confirmed to some extent the details of the mechanism of insertion of the T domain into membranes suggested by the crystal structure of the toxin (Choe et al., 1992; Bennett et al., 1994) . Low pH membrane insertion of diphtheria toxin at the surface of cells has also been described (Papini et al., 1988; Sandvig and Olsnes, 1988; Stenmark et al., 1988) .
We have undertaken to study whether the T domain could be used as a pH triggered membrane anchor for soluble proteins. We have chosen human interleukin-2 (hIL-2) and murine interleukin-3 (mIL-3) as the soluble protein partners because previous work showed that these cytokines could be successfully fused to the catalytic and T domain leading to functional fusion toxins targeted to the corresponding cytokine receptors (Williams et al., 1987 (Williams et al., , 1990 Kiyokawa et al., 1991; vanderSpek et al., 1996; Liger et al., 1997) .
Materials and methods
Bacterial strains, antibodies and cell culture reagents Escherichia coli strain NovaBlue (Novagen, Madison, WI, USA) was used for plasmid propagation and cloning, and strain BL21(DE3) (Novagen) was used as the host for fusion protein production. Mouse monoclonal antibody against hIL-2 Downloaded from https://academic.oup.com/peds/article-abstract/11/11/1111/1478314 by guest on 03 April 2019 was the kind gift of Dr Jacques Grassi (SPI, CEA, France), polyclonal goat anti-mIL-3 antibody was purchased from R&D Systems (Abdington, UK), polyclonal horse anti-diphtheria toxin antibody was obtained from Mérieux (Marcy-l'Etoile, France), rabbit anti-horse IgG-, goat anti-mouse IgG-and rabbit anti-goat IgG-peroxidase conjugates were purchased from Immunotech (Marseilles, France). Cell culture media and reagents were from Biological Industries (Kibbutz Beit Haemek, Israel). The pET11d derived parental plasmid pETJV127 (vanderSpek et al., 1993) encoding DAB 389 -IL-2 was digested with NcoI to introduce a DNA fragment made by hybridization of the following oligonucleotides: 5Ј-CATGGGTCATCACCATCAC-CATCACGATGACGATGACAAATG-3Ј and 5Ј-CATGCATT-TGTCATCGTCATCGTGATGGTGATGGTGATGACC-3Ј. As a result, the N-terminal methionine of the encoded DAB 389 -IL-2 protein is preceded by the following sequence: Met-GlyHis-His-His-His-His-His-Asp-Asp-Asp-Asp-Lys-Cys, and an NsiI restriction site encompasses the Cys codon. The resulting plasmid pCD1 was digested with NsiI to remove the region coding the diphtheria toxin catalytic domain, leading to plasmid pCD2-hIL-2. Plasmid pCC2-hIL-2 was derived from pCD2-hIL-2 by insertion of a DNA fragment made by hybridization of the following oligonucleotides: 5Ј-GTGGCGGTGGA-TCCGGCGGTGGCGGTTCGCATG-3Ј and 5Ј-CGAACCGC-CACCGCCGGATCCACCGCCACCATG-3Ј at its SphI site. As a result, the sequence (Gly 4 -Ser) 2 separates the diphtheria toxin T domain and hIL-2 in the encoded protein.
Construction of vectors pCD2
Plasmids pCD2-mIL-3 and pCC2-mIL-3 were constructed by inserting the SphI-HindIII fragment from plasmid pCGmIL-3 (Liger et al., 1997) in place of the corresponding SphIHindIII fragment in pCD2-hIL-2 and pCC2-hIL-2.
All oligonucleotide insertions were checked by DNA sequence analysis and plasmids were checked by restriction enzyme digestion.
Expression and extraction of the fusion proteins T-hIL-2 and T-(Gly 4 -Ser) 2 -hIL-2
One liter of Terrific Broth [12 g/l tryptone, 24 g/l yeast extract (Difco, Detroit, MI, USA), 0.4% glycerol (v/v), 17 mM KH 2 PO 4 , 72 mM K 2 HPO 4 ] supplemented with 0.2 mg/l ampicillin was inoculated with one colony of BL21(DE3) cells transfected with the corresponding plasmid pCD2-hIL-2 or pCC2-hIL-2. After overnight growth with agitation at 28°C, the culture was diluted if necessary with fresh medium to reach an absorbency at 600 nm of about 0.7 and expression of the recombinant protein was induced by the addition of 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) (Fluka, Buchs, Switzerland) . After 4 h, cells were harvested by centrifugation, resuspended in 15 ml of 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 5% glycerol (v/v), 10 mM imidazole, 5 mM reduced glutathione, 1 mM oxidized glutathione, supplemented with 75 µl of 0.1 M PMSF (Sigma, St Louis, MO, USA) in ethanol and lysed using an Eaton press. The sample was centrifuged at 18 000 r.p.m. for 30 min at 4°C to remove cell debris, the supernatant was treated with 1 µg/ml of DNAse and RNAse 30 min at room temperature and filtered through a 0.45 µm filter.
Expression and extraction of the fusion proteins T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3
Cultures were incubated at 37°C in TSB medium (17 g/l tryptone, 3 g/l Soytone, 5 g/l yeast extract (Difco), 2.5 g/l 1112 K 2 HPO 4 , 5 g/l NaCl) supplemented with 5 g/l glucose and 0.2 mg/l ampicillin. One liter of medium was inoculated with an overnight culture of BL21(DE3) cells carrying plasmid pCD2-mIL-3 or pCC2-mIL-3 at a 1/50 dilution. When the absorbency at 600 nm reached 0.7, expression of the recombinant proteins was induced by the addition of 0.1 mM IPTG. After 2 h, cells were harvested by centrifugation and resuspended in 20 ml of 50 mM Tris-HCl pH 8, 10 mM EDTA, 8% sucrose (w/v), 5% Triton X-100 (v/v) supplemented with 0.1 ml of 0.1 M PMSF (Sigma) in ethanol and 1 ml of a 10 mg/ml solution of lysozyme (Sigma). After 1 h incubation on ice, the cells were lysed by sonication for 5 min (power setting 50%, pulse 1 s, rest 1 s). The preparation was centrifuged at 14 000 r.p.m. for 30 min at 4°C, the pellet containing the inclusion bodies was resuspended in 10 ml of 50 mM Tris-HCl pH 8, 10 mM EDTA, 8% sucrose (w/v), 5% Triton X-100 (v/v) and sonicated and centrifuged similarly three times. The last pellet was solubilized by sonication in 5 ml of 7 M guanidine hydrochloride (Eurobio, Les Ulis, France), 0.1 M sodium phosphate pH 8, 10 mM Tris-HCl pH 8 supplemented with 30 µl of 1 M dithiothreitol (DTT) and filtered through a 0.45 µm filter.
Purification of the fusion proteins T-hIL-2 and T-(Gly 4 -Ser) 2 -hIL-2
The recombinant proteins were purified by immobilized metal ion (Ni 2ϩ ) affinity chromatography (IMAC) using a HisTrap™ kit (Pharmacia, Uppsala, Sweden) with slight modifications of the manufacturer's instructions: after loading with Ni 2ϩ , the HiTrap ® column was equilibrated with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 5% glycerol (v/v), 10 mM imidazole, 5 mM reduced glutathione, 1 mM oxidized glutathione. After loading the protein sample, the column was washed with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 70 mM imidazole, 5 mM reduced glutathione, 1 mM oxidized glutathione and elution was done with 20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 0.5 M imidazole, 5 mM reduced glutathione, 1 mM oxidized glutathione. The eluted proteins were dialyzed against 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5% glycerol (v/v) and stored at -20°C.
Purification and refolding of the fusion proteins T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3
Samples containing the solubilized inclusion bodies were dialyzed twice at room temperature against 8 M urea, 0.1 M sodium phosphate, 10 mM Tris-HCl pH 6 supplemented with 10 mM 2-mercaptoethanol. After loading with Ni 2ϩ , a HiTrap ® column (Pharmacia) was equilibrated with the urea buffer as described above and loaded with the dialyzed sample. The column was washed with urea buffer, and then with refolding buffer (50 mM Tris-HCl pH 8, 50 mM NaCl, 5 mM reduced glutathione, 1 mM oxidized glutathione). The flow of refolding buffer was stopped, and the column was allowed to rest overnight at 4°C. Proteins were eluted with refolding buffer supplemented with 0.5 M imidazole, and the eluted samples were dialyzed against 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5% glycerol (v/v) and stored at -20°C.
Some aggregation of the T fusion proteins could be observed by dynamic light scattering. This problem has been solved by keeping the proteins at a concentration below 1 mg/ml in the presence of 5% glycerol. Any remaining aggregates could be removed by centrifugation for 20 min at 14 000 r.p.m.
Cell culture and proliferation assays
The IL-2 dependent murine spleen cell line CTLL-2 (Gillis et al., 1978) was cultured in RPMI-1640 supplemented with 5% fetal calf serum, 2 mM glutamine, 10 mM HEPES, 100 µg/ml gentamicin, 50 µM 2-mercaptoethanol and 10% rat splenocyte conditioned media as a source of IL-2. The mIL-3 dependent murine myelomonocytic cell line FDC-P1 (Dexter et al., 1980) was cultured in α-MEM supplemented with 10% fetal calf serum, 2 mM glutamine, 100 µg/ml gentamicin and 4% WEHI-3B conditioned media as a source of mIL-3 (Brazill et al., 1983) .
Proliferation assays were performed with the same media without the conditioned media as cytokine source. Cells were seeded at a density of 10 4 cells per well into 96-well flat bottom culture plates (Nunc). The cells were exposed to various concentrations of the fusion proteins or recombinant hIL-2 or mIL-3 as controls in a final volume of 0.15 ml. Cells were incubated at 37°C in a 6% CO 2 atmosphere for 20 h in the CTLL-2 assay and for 36 h in the FDC-P1 assay. [ 3 H]thymidine (1 µCi/well; Amersham) was added, and after incubation for 6 h at 37°C in a 6% CO 2 atmosphere, cells were collected by aspiration on a glass-fiber filter using a TOMTEC Harvester 96 and radioactivity was counted in a 1450 MicroBeta liquid scintillation counter (Wallac, Turku, Finland) . Liposome permeabilization assay Large unilamellar vesicles (LUV) were prepared by reverse phase evaporation as described (Rigaud et al., 1983 ) using a mixture of egg phosphatidylcholine and egg phosphatidic acid (Avanti Polar-lipids, Alabaster, AL, USA) at a molar ratio of 9:1. The buffer used for preparation was 25 mM KH 2 PO 4 , 50 mM K 2 SO 4 , 50 mM Na 2 SO 4 , 25 mM Mes pH 7.4 supplemented with 0.2 mM pyranine (Molecular Probes, Eugene, OR, USA). The preparation was extruded through 0.4 and 0.2 µm polycarbonate filters (Millipore, Bedford, MA, USA) to obtain LUV of a uniform size distribution of about 120 nm. The final phospholipid concentration was about 16 mg/ml (20 mM). LUV were separated from non-entrapped pyranine by size exclusion chromatography on a G50-Sephadex column.
LUV suspension (50 µl) was added to 950 µl of the buffer used for the vesicle preparation (without pyranine) in a quartz cuvette in a spectrofluorimeter LS 50 (Perkin-Elmer) under constant magnetic stirring at 37°C. Excitation was performed at 460 nm and emission was recorded at 510 nm. In a typical experiment of 200 s, the following reagents were added sequentially: at t ϭ 0 s, 2 µl of 0.1 mM valinomycin (Sigma) in ethanol; at t ϭ 15 s, 38 µl of 1 M H 2 SO 4 ; at t ϭ 40 s, protein samples; at t ϭ 140 s, 2 µl of 0.1 mM carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) (Sigma) in ethanol; at t ϭ 180 s, 38 µl of 1 M KOH. Diphtheria toxin (Sigma) used as a control was nicked with trypsin (Carroll et al., 1988) and reduced with 20 mM DTT. Preincubation of the proteins with antibodies was done by mixing an excess of purified antibodies with the protein sample 5 min before adjunction to the quartz cuvette. Liposome floatation experiments LUV containing pyranine were prepared as described above. 0.8 mg of LUV were incubated at 20°C with 20 µg of protein in 350 µl of 20 mM Tris, 150 mM NaCl pH 7.4 and pH was dropped to 5 or maintained at 7.4 by the adjunction of 50 µl of 250 mM Mes at pH 3.4 or 7.4. At this step, concentrations were 2.5 mM for lipids and 1.3ϫ10 -6 M for proteins. After incubation overnight, samples were then mixed to a 60% sucrose, 20 mM Tris, 150 mM NaCl solution to reach 40% sucrose. A 40, 30, 20, 10 and 5% discontinuous sucrose gradient was made for each sample in a 8 ml Beckman 1113 polycarbonate ultracentrifuge tube. Gradients were centrifuged 1 h at 110 000 g in a fixed angle rotor. The top 5% sucrose fraction and the bottom 40% sucrose fraction were harvested and analyzed for the presence of proteins by slot blotting and western detection, and for the presence of pyranine by fluorescence detection (excitation at 465 nm and emission at 530 nm) after dilution 1/4 in 1 M Tris-HCl pH 8, 0.1% SDS.
Liposome enzyme linked immunofiltration assay (lipo-ELIFA)
Lipo-ELIFA was inspired from studies of compound/vesicle interactions by perfusion of compounds through filters onto which vesicles were immobilized by adsorption (Champeil and Guillain, 1986; le Maire et al., 1987) . Small unilamellar vesicles (SUV) were prepared by sonication of a dispersion of 50 mg egg phosphatidylcholine and 5 mg egg phosphatidic acid in 3 ml of PBS pH 7.4 (Sigma) for 5 min. The final phospholipid concentration of the preparation was 18.3 mg/ml (22.9 mM). The assay was performed on 96-well Multiscreen ® -HA 0.45 µm mixed esters of cellulose filter plates (Millipore). At each step, 200 µl/well of each solution was applied to the plate and vacuum-filtered using a Millipore MultiScreen device. All dilutions and washes were done with PBS pH 7.4 unless otherwise stated. SUV diluted 1/8 th were first adsorbed on the filters. This amount was chosen in order to saturate the highly charged filters with vesicles to prevent non-specific binding of proteins through electrostatic interactions in subsequent incubations. Filters were further saturated with PBS containing 0.3% BSA (Sigma) (w/v) and washed once. This saturation step decreased nonspecific binding of antibodies. Recombinant protein (10 µg) were added in PBS at pH 7.4 or at pH 5 followed by a wash. Filters were incubated again with BSA and washed three times. Mouse monoclonal anti-hIL-2 or goat polyclonal anti-mIL-3 antibodies diluted 1/1000 in PBS supplemented with 0.1% BSA were added, plates were washed three times, goat anti-mouse or rabbit anti-goat IgG-peroxidase conjugate at a 1/5000 dilution in PBS supplemented with 0.1% BSA were added, and plates were washed three times. Twenty five µl of ABTS substrate solution (Pierce, Rockford, Il, USA) prepared according to the manufacturer's instructions was added and the filtrates were harvested in a 96-well ELISA plate placed inside the Millipore MultiScreen device. Finally, the wells were rinsed with 200 µl PBS to ensure good recovery of the substrate transformed by the peroxidase. ELISA plates were read in a Titertek Multiscan MCC 340 spectrophotometer at 414 nm. Cell surface binding immunodetection assay Adherent fibroblastic mouse L cells (10 5 /well) were seeded on 96-well plates (Nunc) in Dulbecco-MEM supplemented with 10% fetal calf serum and 2 mM glutamine and grown overnight to confluence at 37°C in a 6% CO 2 atmosphere. Cells were washed three times with PBS at pH 7.4. The T-cytokine fusion proteins were diluted in PBS at pH 5 or at pH 7.4, and 50 µl per well of each dilution were incubated with the cells at 20°C for 15 min. The cells were washed three times with PBS at pH 7.4. One hundred µl of mouse monoclonal anti-IL-2 antibody or goat polyclonal anti-mIL-3 antibody (stock solution 1 mg/ml) at a 1/1000 dilution in PBS supplemented with 0.1% BSA were added to the cells at 4°C for 1 h. After three washes with PBS, the cells were incubated with 100 µl of the corresponding goat anti-mouse or rabbit anti-goat IgG-peroxidase conjugate at a 1/5000 dilution in PBS supplemented with 0.1% BSA at 4°C for 1 h. After three washes with PBS, plates were developed with 200 µl of ABTS (Pierce) according to Met-Gly-His 6 -Asp 4 -Lys Cys201-Thr386 His-(Gly 4 -Ser) 2 -His hIL-2-Ala1-Thr133 T-mIL-3
Met-Gly-His 6 -Asp 4 -Lys Cys201-Thr386 His-Ala mIL-3-Asp7-Cys140 T-(Gly 4 Ser) 2 -mIL-3
Met-Gly-His 6 -Asp 4 -Lys Cys201-Thr386 His-(Gly 4 -Ser) 2 -His-Ala mIL-3-Asp7-Cys140 the manufacturer's instructions and absorbency at 414 nm was read in a Titertek 340nm spectrophotometer. For fluorescence studies on the non adherent cell line FDC-P1, the protocol was similar except that cells were washed by centrifugation and that the peroxidase conjugated antibody was replaced with a FITC-conjugated goat anti-mouse IgG antibody (Sigma). Table I summarizes the primary structure of the four fusion proteins that we have constructed. The corresponding expression plasmids are described in Materials and methods. All four proteins have an N-terminal 6His tag for IMAC purification, followed by an enterokinase proteolytic cleavage site preceding the diphtheria toxin T domain represented by amino acid residues Cys201 to Thr386 of the mature toxin (Choe et al., 1992; Bennett et al., 1994) . The complete sequence for mature hIL-2 (133 amino acid residues) (Williams et al., 1987) was fused to the T domain in proteins T-hIL-2 and T-(Gly 4 -Ser) 2 -hIL-2. In the case of the mIL-3 fusions, amino acid residues Asp7 to Cys140 of the mature cytokine were linked to the T domain leading to proteins T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3. Two N-terminal variants of native mIL-3, containing either 140 or 134 amino acid residues, have been described in mice. It is believed that the shorter form arises from secondary proteolytic cleavage. Nevertheless, both forms have comparable activities in vitro (Schrader, 1986) . For each cytokine, two fusion proteins were constructed with or without the introduction of the flexible hydrophilic spacer (Gly 4 -Ser) 2 between the T domain and the cytokine. This was intended to study whether an increased distance between the T domain and the cytokine would improve recognition of the latter by specific antibodies or by the corresponding receptor (Kiyokawa et al., 1991; Sasaki et al., 1995; Gelhausen et al., 1996; Liger et al., 1997) .
Results

Fusion of hIL-2 or mIL-3 to the diphtheria toxin T domain
After expression and purification, the final yields of recovery of the four fusion proteins T-hIL-2, T-(Gly 4 -Ser) 2 -hIL-2, T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3 were about 2-4 mg per liter of culture. Coomassie blue staining of the fusion proteins following SDS-PAGE shows that they have been purified to over 90% homogeneity (Figure 1) . The proteins have an electrophoretic mobility consistent with the expected molecular masses deduced from their amino acid sequences: 37.3 and 38.1 kDa for proteins T-hIL-2 and T-(Gly 4 -Ser) 2 -hIL-2, respectively, and 37.1 and 37.9 kDa for T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3, respectively. Moreover, after SDS-PAGE, electrotransfer onto a nylon membrane and western detection, the proteins reacted with both anti-diphtheria toxin and anti-hIL-2 or antimIL-3 antibodies (not shown).
Cytokine activity of the T-cytokine fusion proteins
We have studied the capacity of the T-cytokine fusion proteins to recognize and activate the IL-2 or mIL-3 receptor to evaluate the structural and functional integrity of the cytokine domain of the fusions. Figure 2A shows that T-hIL-2 and T-(Gly 4 -Ser) 2 -hIL-2 were able to sustain the proliferation of IL-2 dependent CTLL-2 cells in a dose dependent manner. Both proteins had the same stimulation activity with an EC 50 ϭ 10 -10 M. This value is 10 times less than the activity we observed with recombinant hIL-2 (EC 50 ϭ 10 -11 M). Interestingly, the same difference in stimulation activity was found previously between recombinant hIL-2 and the fusion toxin DA(E149S)B 389 IL-2 (vanderSpek et al., 1996) . It is a fusion protein in which a mutated nontoxic catalytic domain from diphtheria toxin and the T domain are linked to hIL-2.
Similarly, Figure 2B shows that T-mIL-3 and T-(Gly 4 -Ser) 2 -mIL-3 can stimulate mIL-3 dependent FDC-P1 cells with an EC 50 ϭ 2ϫ10 -10 M. This stimulation capacity was found 40-fold less than that of recombinant mIL-3 (EC 50 ϭ 5ϫ10 -12 M).
Taken together, these results show that the T-cytokine fusion proteins are able to bind to and activate their corresponding cytokine receptor. This suggests proper folding and fairly good accessibility of both cytokines within the fusion proteins. The diminished receptor binding activity of a fusion protein compared with the unfused active moiety is a classical phenomenon observed in numerous cases (Gillet et al., 1992; vanderSpek et al., 1996) and generally attributed to steric hindrance due to the fusion partner. The presence or absence of the (Gly 4 -Ser) 2 spacer does not affect the proliferation activity of the fusion proteins.
Treatment of the proteins 1 h at pH 5 did not alter their cell proliferation activity (not shown). This is important as anchoring to lipid membranes requires acidic pH treatment. 
pH triggered insertion of the T-cytokine fusion proteins in the membrane of vesicles
pH triggered insertion of the recombinant proteins into membranes was monitored by measurements of the permeabilization of LUV to small molecules. Diphtheria toxin nicked with trypsin (Carroll et al., 1988) and reduced with DTT in order to separate the A chain (catalytic domain) from the B chain containing the T domain and the receptor binding domain, was used as a control. The pH sensitive fluorescent probe pyranine was entrapped into LUV and the excess non-entrapped pyranine was eliminated by size exclusion chromatography. The lipophilic ionophore valinomycin, which specifically carries K ϩ ions across membranes, was added to allow for the exchange of K ϩ in case of proton entry into the LUV. This was intended to prevent the formation of a transmembrane electrical potential gradient due to H ϩ entry which in turn could affect H ϩ flow across the membrane. The fluorescence of pyranine, which is high at neutral pH and greatly reduced at acidic pH, was monitored during the experiment.
First, the pH of the external compartment was dropped from 7.4 to 5. At this point, the fluorescence of the system decreased about 10% due to extinction of the small amount of pyranine remaining outside the LUV ( Figure 3A) . Then, the T-cytokine fusion proteins were added to the cuvette. Rapid extinction of the fluorescence was observed over a period of 100 s ( Figure 3A ) indicating rapid titration of pyranine by H ϩ . To reach a maximum effect, 20 to 40 µg of proteins were necessary depending on the fusion protein ( Figure 3D ). This corresponds to a final concentration of 0.5 to 1ϫ10 -6 M, which represents an average of about 90 molecules per liposome. Presence or absence of valinomycin did not affect the response. Adjunction of FCCP, a lipophilic ionophore specific for H ϩ was performed to permeabilize the remaining intact LUV, leading to total extinction of fluorescence. Valinomycin was necessary at this point to observe permeabilization by FCCP. Finally, changing back the pH to 7.4 returned the fluorescence to the initial level. The results shown in Figure 3 were obtained with the T-mIL-3 protein. Similar results were observed with the other T-cytokine fusion proteins.
Titration of pyranine in the assay could be due to entry of H ϩ into the vesicles, the pyranine molecules remaining entrapped, or to non-selective leakage of the vesicles leading to mixing of pyranine and H ϩ in and out of the vesicles. Indeed, leakage of molecules from vesicles upon insertion of diphtheria toxin (London, 1992) or the isolated T domain (Zhan et al., 1995) have been described. The latter was demonstrated by adjunction to the quartz cuvette of 20 mM of DPX, a quencher of pyranine fluorescence ( Figure 3B ). Under these conditions, fluorescence was not recovered after neutralization at the end of the experiment when assaying the fusion proteins, revealing mixing of pyranine and DPX. In contrast, fluorescence was entirely recovered when performing the assay with FCCP alone which is known to permeabilize the vesicles to H ϩ only (not shown). Finally, no fluorescence modification was observed when the LUV were incubated with the fusion proteins at pH 7.4 in the presence of DPX ( Figure 3B ). This indicates that the proteins do not permeabilize the vesicles at this pH.
Interestingly, preincubation of the proteins with an excess of anti-diphtheria toxin antibodies, but not anti-IL-2 or anti-mIL-3 antibodies, prevented membrane permeabilization ( Figure 3C ). Antibodies alone had no effect on membrane permeability in the same conditions of acidic pH (not shown).
All four T-cytokine fusion proteins were able to perforate the LUV in similar fashion to diphtheria toxin ( Figure 3A and D) . However, the perforation efficiency of the recombinant proteins was slightly reduced compared with that of diphtheria toxin, by a factor of 3 to 6 on a molar basis depending on the protein ( Figure 3D ). These variations in perforation efficacy do not seem related to the presence or absence of the (Gly 4 -Ser) 2 spacer, as similar variations in efficiency were observed for different preparations of each single protein.
Taken together, these results strongly suggest that the T-cytokine fusion proteins are able to insert into membranes at acidic pH through their T domain. The presence of antibodies bound to the cytokine does not prevent insertion.
Liposome floatation experiments
It is possible to separate liposomes or proteoliposomes from soluble proteins by floatation on a sucrose gradient (Rigaud et al., 1988) . In such experiments, proteins remain in the high sucrose concentration fraction due to their relatively high density while liposomes having lower densities float towards low sucrose concentration layers. Proteoliposomes float towards intermediary or low sucrose concentration layers depending on their lipid/protein ratio. We have used this technique to study the Comparison of the effect of varying concentrations of diphtheria toxin and T-mIL-3. The 100% pyranine released was defined as the maximum of pyranine extinction which could be observed due to the effect of the proteins, although pyranine fluorescence was not totally abolished.
correlation, if any, between permeabilization of liposomes and binding of the T-cytokine proteins to their surface. LUV containing pyranine were incubated overnight with each T-cytokine fusion protein at pH 5 or 7.4. Each sample was then submitted to centrifugation on a 40-5% sucrose gradient. After centrifugation, turbidity due to the presence of liposomes was clearly visible on top of the gradient in the 5% sucrose fraction and at the 5-10% sucrose fraction interface. Figures 4A and B show that when incubated with the LUV at pH 7.4, about two-thirds of the protein remained in the 40% sucrose fraction while onethird associated with the vesicles. In this case, pyranine was dragged to the 5% sucrose fraction with the LUV, revealing an absence of permeabilization throughout the experiment ( Figure 4C ). In contrast, when incubations were performed at pH 5, proteins co-migrated to the 5% sucrose fraction with the LUV and pyranine remained in the 40% sucrose fraction indicating permeabilization of the vesicles. In the absence of proteins, pyranine was found in the 5% sucrose fraction after incubation of LUV at both pH ( Figure 4C ).
Altogether these results show a correlation between permeabilization and association of the proteins to the LUV. Occurrence 1116 of both phenomena relies necessarily on the presence of the proteins and the acidic pH together. Nevertheless, the proteins bind to the LUV at pH 7.4 to some extent, but without permeabilizing them.
Antibody recognition of the hIL-2 or mIL-3 domains of the T-cytokine fusion proteins anchored to the surface of vesicles
To further characterize the pH triggered insertion of the Tcytokine fusion proteins into phospholipid membranes, we designed a lipo-ELIFA as described in Materials and methods. This assay was intended to study the accessibility of the cytokines to antibodies once anchored to the membrane. The principle of the lipo-ELIFA is similar to that of an ELISA in which the solid phase is a filter on which SUV are adsorbed to saturation. Incubations with the proteins to be analyzed and the antibodies, as well as washes, are performed by filtration of solutions through the filter. T-cytokine fusion proteins were put in contact with the vesicles either at pH 7.4 or 5. After washing thoroughly at pH 7.4, antibodies specific for each cytokine were passed through the filters followed by antiIgG-peroxidase conjugates and a colorimetric substrate of peroxidase. The results in Figure 5 show a marked increase in binding of the T-cytokine fusion proteins to membranes at acidic pH compared with neutral pH. This is in good agreement with the observations made in the sucrose gradient experiments. Saturation of the filters with the vesicles was critical. In the absence of SUV, high non-specific binding of proteins and antibodies occurred, whatever the pH. Presence or absence of the (Gly 4 -Ser) 2 spacer did not significantly modify the results, suggesting that it influences neither anchoring of the T domain nor accessibility of the bound cytokines to antibody recognition.
pH triggered binding of the T-cytokine fusion proteins to the membrane of cells
Adherent fibroblastic L cells were incubated with varying amounts of each T-cytokine fusion protein from 5 to 0.04 µg per well (2.6ϫ10 -6 to 2ϫ10 -8 M) at pH 5 or 7.4. After washing, the presence of cytokines on the cell surface was determined by immunodetection ( Figure 6 ). The results show clearly that the fusion proteins attach to cells in a dose dependent manner, at pH 5 but not at pH 7.4. Similar results were obtained with the adherent breast carcinoma cell line SKBR3 (not shown). Interestingly, viability of the cells was not affected by the treatment (not shown).
Similar experiments were done with T-(Gly 4 Ser) 2 -hIL-2 on the non-adherent cell line FDC-P1, using a FITC labeled goat anti-mouse-IgG antibody as the secondary antibody. Fluorescence microscopy observations are shown Figure 7 . Labeling of cells occurred only when they were incubated with T-(Gly 4 Ser) 2 -hIL-2 at pH 5, but not at pH 7.4 nor at acidic pH in the absence of the fusion protein.
Kinetic studies of the attachment of the T-cytokine fusion proteins to L cells were performed. The proteins were incubated with the cells at pH 5 for various time periods from 1 to 15 min. Maximal binding occurred within minutes (not shown). Once bound, the T-cytokines remained on the cell surface without much loss for at least 4 h (not shown).
Discussion
In this work, we have shown that fusion proteins made of a cytokine and the T domain of diphtheria toxin are able to bind to the surface of lipid vesicles or living cells at acidic pH. Binding to lipid vesicles correlates with permeabilization of their membrane. Permeabilization did not depend on the cytokine in the fusion proteins (hIL-2 or mIL-3) and was inhibited with antibodies against diphtheria toxin, but not with antibodies against the cytokines. This permeabilization occurs with the whole diphtheria toxin, in our experiments as well as in previous works (reviewed in London, 1992) and has been described also for the isolated T domain (Zhan et al., 1995) . Moreover, convincing evidence has been published on the pH dependent insertion into membranes of the T domain, isolated (Zhan et al., , 1995 Wang et al., 1997b) or in the native toxin (London, 1992; O'Keefe et al., 1992; Cabiaux et al., 1994; Madshus et al., 1994; Mindell et al., 1994; Silverman et al., 1994; Quertenmont et al., 1996; Wang et al., 1997a) . Considering these reports, our data strongly suggest that acidic pH provokes binding of the T-cytokine fusion proteins to the membrane of vesicles through insertion of their T domain into the membrane.
Significant binding is also observed at neutral pH, on liposomes in solution (floatation experiments) or bound to filters (lipo-ELIFA experiments). However, this binding does not provoke permeabilization of the vesicles. This suggests that binding at neutral pH does not correspond to an insertion into the membrane, but rather to an adsorption to its surface maybe through electrostatic interactions. Association of diphtheria toxin to synthetic membranes at neutral pH was previously reported but apparently does not correspond to membrane insertion (reviewed in London, 1992) .
The interaction of the T domain with the surface of cells 1118 seems to be different than what is observed with vesicles. No binding occurs at neutral pH. At acidic pH, proteins bind to the cell surface and remain detectable for at least 4 h without affecting cell viability (not shown). This suggests that the cell membranes are not permeabilized and questions whether or not the T domain penetrates the lipid bilayer. Indeed, two types of interactions with cell membranes have been described for diphtheria toxin (Stenmark et al., 1988) . When the toxin is first allowed to bind to its receptor it inserts into the membrane leading to the formation of a channel (Papini et al., 1988; Sandvig and Olsnes, 1988; Stenmark et al., 1988) . In the absence of receptor, as this is the case in our study, cells are not permeabilized and the interaction is superficial (Stenmark et al., 1988) . Recently, shallow and deep membrane penetrating forms of the T domain have been described (Wang et al., 1997b) . Altogether, it appears that different types of interactions may be observed depending on the complexity and characteristics of the membranes. Once bound to the surface of vesicles or living cells, the cytokine domain of the T-cytokine fusion proteins remains accessible to recognition by antibodies. Thus, we propose that the T domain may be used as a membrane anchor for water soluble proteins fused at its C-terminus. Its most interesting feature for this purpose is the triggering of membrane insertion by a drop in pH to values around 5 or even higher (London, 1992; Zhan et al., 1995) . Such pH is well tolerated by many synthetic membrane systems, living cells and many proteins, including the cytokines used in this study. Insertion is rapid, as vesicle permeabilization occurs within seconds at protein concentrations around 5ϫ10 -7 M. If proteins are added before the pH drop (not shown), the kinetics of insertion are even faster, suggesting that the rate limiting step in the process is the diffusion of the protein leading to membrane encounter. This is also suggested by the kinetics of binding to cells, most of the effect occurring within minutes (not shown).
We have investigated whether the distance between the T domain and the cytokines would influence recognition of the cytokines by their cell surface receptor, or by antibodies once anchored to membranes, as suggested by previous observations (Kiyokawa et al., 1991; Sasaki et al., 1995; Gelhausen et al., 1996; Liger et al., 1997) . This was not the case. An explanation is that in our constructs, the T domain is followed by residues 378 to 386 of diphtheria toxin which could behave as a natural spacer sticking out on top of the T domain.
One drawback might be discussed for the use of the T domain as an anchor. The inserted T domain modifies the permeability of vesicles allowing for leakage of compounds of significant molecular mass as observed previously (London, 1992; Zhan et al., 1995) as well as in this study. It is an important drawback if one wants to entrap compounds into liposomes for cell receptor targeting. Whether the lipid composition of the membrane might influence this phenomenon must be investigated. Anyway, the development of new lipid vehicles such as multilamellar vesicles or vesosomes (a few vesicles entrapped in a larger one) (Walker et al., 1997) may be an answer to this problem.
Application of our system for the targeting of vesicles to cell receptors are under study. Usually, this is done by linking antibodies or sugars to the vesicles, but cytokines which have stronger affinities for their receptors may improve the efficacy of liposome targeting. Other applications may be found for the anchoring of proteins to membranes using the T domain. These include cell tagging, enzyme anchoring or ligandreceptor studies.
